tradingkey.logo
๎™

LeMaitre Vascular Inc

LMAT
์ƒ์„ธ ์ฐจํŠธ ๋ณด๊ธฐ

94.380USD

+1.760+1.90%
์ข…๊ฐ€ย 08/12, 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
2.14B์‹œ๊ฐ€์ด์•ก
47.31P/E TTM
๎™

LeMaitre Vascular Inc

94.380

+1.760+1.90%
Intraday
1m
30m
1h
D
W
M
D

์˜ค๋Š˜

+1.90%

5์ผ

+10.26%

1๊ฐœ์›”

+12.78%

6๊ฐœ์›”

-2.01%

์˜ฌํ•ด ํ˜„์žฌ๊นŒ์ง€

+2.43%

1๋…„

+14.96%

์ƒ์„ธ ์ฐจํŠธ ๋ณด๊ธฐ

๊ธฐ๊ด€ ๋“ฑ๊ธ‰๎˜ฐ๎˜ฐ

์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€

11 ๋ช…์˜ ๋ถ„์„๊ฐ€๋ฅผ ๊ธฐ์ค€์œผ๋กœ
BUY
ํ˜„์žฌ ๋“ฑ๊ธ‰
104.778
๋ชฉํ‘œ ๊ฐ€๊ฒฉ
13.13%
์ƒ์Šน ์—ฌ๋ ฅ
๊ฐ•๋ ฅ ๋งค์ˆ˜
๋งค์ˆ˜
์œ ์ง€
๋งค๋„
๊ฐ•๋ ฅ ๋งค๋„

๋™์ข…์—…๊ณ„ ๋น„๊ต

96
์ด๊ณ„
4
์ค‘๊ฐ„
6
ํ‰๊ท 
ํšŒ์‚ฌ ์ด๋ฆ„
ํ‰๊ฐ€
๋ถ„์„๊ฐ€
LeMaitre Vascular Inc
LMAT
11
Boston Scientific Corp
BSX
36
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
34
Veeva Systems Inc
VEEV
32
Thermo Fisher Scientific Inc
TMO
31
1
2
3
...
19

์ง€ํ‘œ

๎˜ฐ
๎˜ฐ

์ง€ํ‘œ ๊ธฐ๋Šฅ์€ ๋‹ค์–‘ํ•œ ๊ธฐ๋ฒ• ์ง€ํ‘œ๋ฅผ ๊ธฐ๋ฐ˜์œผ๋กœ ์—ฌ๋Ÿฌ ์ข…๋ชฉ์— ๋Œ€ํ•œ ๊ฐ€์น˜์™€ ๋ฐฉํ–ฅ ๋ถ„์„์„ ์ œ๊ณตํ•˜๋ฉฐ, ๊ธฐ์ˆ ์  ์š”์•ฝ๋„ ํ•จ๊ป˜ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค.

์ด ๊ธฐ๋Šฅ์—๋Š” ์ผ๋ฐ˜์ ์œผ๋กœ ์‚ฌ์šฉ๋˜๋Š” 9๊ฐ€์ง€ ๊ธฐ์ˆ ์  ์ง€ํ‘œ๊ฐ€ ํฌํ•จ๋ฉ๋‹ˆ๋‹ค: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX, MA. ๋˜ํ•œ ํ•„์š”์— ๋”ฐ๋ผ ์‹œ๊ฐ„ ํ”„๋ ˆ์ž„์„ ์กฐ์ •ํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

๊ธฐ์ˆ  ๋ถ„์„์€ ํˆฌ์ž ์ฐธ์กฐ์˜ ์ผ๋ถ€์ผ ๋ฟ์ด๋ฉฐ, ๋ฐฉํ–ฅ์„ ํ‰๊ฐ€ํ•˜๊ธฐ ์œ„ํ•ด ์ˆซ์ž ๊ฐ’์„ ์‚ฌ์šฉํ•˜๋Š” ๋ฐ์—๋Š” ์ ˆ๋Œ€์ ์ธ ๊ธฐ์ค€์ด ์—†์Šต๋‹ˆ๋‹ค. ๊ฒฐ๊ณผ๋Š” ์ฐธ์กฐ์šฉ์ผ ๋ฟ์ด๋ฉฐ, ์ง€ํ‘œ ๊ณ„์‚ฐ ๋ฐ ์š”์•ฝ์˜ ์ •ํ™•์„ฑ์— ๋Œ€ํ•ด์„œ๋Š” ์ฑ…์ž„์ง€์ง€ ์•Š์Šต๋‹ˆ๋‹ค.

1๋ถ„
15๋ถ„
30๋ถ„
1์‹œ๊ฐ„
์ผ๊ฐ„
์ฃผ๊ฐ„
์›”๊ฐ„
1๋ถ„
15๋ถ„
30๋ถ„
์ผ๊ฐ„๎˜ฎ
๋งค์ˆ˜
๋งค๋„(2)
์ค‘๋ฆฝ(2)
๋งค์ˆ˜(8)
์ง€ํ‘œ
๋งค๋„(2)
์ค‘๋ฆฝ(2)
๋งค์ˆ˜(2)
์ง€ํ‘œ
๊ฐ€์น˜
๋ฐฉํ–ฅ
MACD(12,26,9)
2.729
๋งค์ˆ˜
RSI(14)
72.345
๋งค์ˆ˜
STOCH(KDJ)(9,3,3)
81.038
์ค‘๋ฆฝ
ATR(14)
2.940
๊ณ ๋ณ€๋™์„ฑ
CCI(14)
97.772
์ค‘๋ฆฝ
Williams %R
14.654
๊ณผ๋งค๋„
TRIX(12,20)
0.367
๋งค๋„
StochRSI(14)
44.043
๋งค๋„
์ด๋™ ํ‰๊ท 
๋งค๋„(0)
์ค‘๋ฆฝ(0)
๋งค์ˆ˜(6)
์ง€ํ‘œ
๊ฐ€์น˜
๋ฐฉํ–ฅ
MA5
93.354
๋งค์ˆ˜
MA10
88.098
๋งค์ˆ˜
MA20
84.797
๋งค์ˆ˜
MA50
83.766
๋งค์ˆ˜
MA100
83.921
๋งค์ˆ˜
MA200
90.027
๋งค์ˆ˜

๋‰ด์Šค

๋” ๋งŽ์€ ๋‰ด์Šค๊ฐ€ ๊ณง ์—…๋ฐ์ดํŠธ๋ฉ๋‹ˆ๋‹ค. ๊ณ„์† ์ง€์ผœ๋ด ์ฃผ์„ธ์š”โ€ฆ

์žฌ๋ฌด ์ง€ํ‘œ๎˜

EPS

๋ฐ์ดํ„ฐ ์—†์Œ

์ด ์ˆ˜์ต

๋ฐ์ดํ„ฐ ์—†์Œ

ํšŒ์‚ฌ๎˜

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Companyโ€™s principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.
์ข…๋ชฉ ์ฝ”๋“œ LMAT
ํšŒ์‚ฌLeMaitre Vascular Inc
CEOMr. George W. Lemaitre
์›น์‚ฌ์ดํŠธhttps://www.lemaitre.com/
tradingkey.logo
tradingkey.logo
๋‹น์ผ ๊ฑฐ๋ž˜ ๋ฐ์ดํ„ฐ๋Š” Refinitiv์—์„œ ์ œ๊ณตํ•˜๋ฉฐ, ์ด์šฉ ์•ฝ๊ด€์ด ์ ์šฉ๋ฉ๋‹ˆ๋‹ค. ์—ญ์‚ฌ์  ๋ฐ ํ˜„์žฌ ์ข…๊ฐ€ ๋ฐ์ดํ„ฐ๋Š” Refinitiv์—์„œ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ๋ชจ๋“  ์‹œ์„ธ๋Š” ํ˜„์ง€ ๊ฑฐ๋ž˜์†Œ ์‹œ๊ฐ„ ๊ธฐ์ค€์ž…๋‹ˆ๋‹ค. ๋ฏธ๊ตญ ์ฃผ์‹ ์‹œ์„ธ์˜ ์‹ค์‹œ๊ฐ„ ๋งˆ์ง€๋ง‰ ๊ฑฐ๋ž˜ ๋ฐ์ดํ„ฐ๋Š” Nasdaq์„ ํ†ตํ•ด ๋ณด๊ณ ๋œ ๊ฑฐ๋ž˜๋งŒ ๋ฐ˜์˜๋ฉ๋‹ˆ๋‹ค. ๋‹น์ผ ๊ฑฐ๋ž˜ ๋ฐ์ดํ„ฐ๋Š” ์ตœ์†Œ 15๋ถ„ ์ง€์—ฐ๋˜๊ฑฐ๋‚˜ ๊ฑฐ๋ž˜์†Œ ์š”๊ตฌ ์‚ฌํ•ญ์— ๋”ฐ๋ผ ๋‹ค๋ฅผ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
* ์ฐธ๊ณ ์ž๋ฃŒ, ๋ถ„์„ ๋ฐ ํŠธ๋ ˆ์ด๋”ฉ ์ „๋žต์€ ์ œ3์ž ์ œ๊ณต์—…์ฒด์ธ Trading Central์—์„œ ์ œ๊ณตํ•˜๋ฉฐ, ๋ถ„์„๊ฐ€์˜ ๋…๋ฆฝ์ ์ธ ํ‰๊ฐ€์™€ ํŒ๋‹จ์— ๊ธฐ๋ฐ˜ํ•œ ์‹œ๊ฐ์œผ๋กœ, ํˆฌ์ž์ž์˜ ํˆฌ์ž ๋ชฉํ‘œ์™€ ์žฌ์ • ์ƒํ™ฉ์€ ๊ณ ๋ ค๋˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
KeyAI
๎™